Samsung Biologics signs $1.29 billion deal with US pharma firm
Samsung Biologics signs $1.29 billion deal with US pharma firm Seoul, Sep 9 (IANS/WISHAVWARTA) Samsung Biologics, South Korea's leading biotech firm, said on Tuesday it has secured a 1.8 trillion-won ...

















